Antares Pharma, Inc. (ATRS)

[jab91252]

Biopete:

"not a big fan of the Pfizer deal".....

You are, of course, talking about the 'undisclosed' deal and as such us outsiders do not know of any of the details. Knowing you the way I do know you (from the historical posting relationship) I suspect you would say the same thing for any pharma deal where the details are undisclosded. At least you are consistent from my perspective.

To me, from the last available disclosure on the subject, it looks like they are making investors aware of the 3 year time frame.


EWING, N.J. (AP) -- Antares Pharma Inc. said Tuesday it received a $750,000 milestone payment from its partner Pfizer Inc.
Antares said the payment was related to the development of an undisclosed consumer health care product. In December 2011 Antares licensed drug delivery technology to Pfizer. Pfizer agreed to give Antares an upfront payment and milestone payments related to development and sales of the product, as well as royalties on any sales made in the first three years after product approval.
Shares of Antares Pharma rose 12 cents, or 2.8 percent, to $4.40 on Tuesday.

CEO Wotton might even agree with you with respect to the big picture. But these deals, while we don't know the true financial impact, all help fund the in-house, come to mama revenue generators.
jab9